Karyopharm Therapeutics Inc is a clinical-stage pharmaceutical company focused on the discovery, development and subsequent commercialization of drugs directed against nuclear transport targets for the treatment of cancer and other diseases.
| Website: | www.karyopharm.com |
| Main Phone: | +1 617 658-0600 |
| Address: | 85 Wells Avenue |
| Address 2: | 2nd Floor |
| State: | MA |
| City / Town: | Newton |
| Country: | USA |
| Postal Code: | 02459 |
| Exchange: | NGS |
| Employees: | 105 |
| NAICS: | Pharmaceutical P |
| Last Price 8.80 | Change $ -0.34 | Change % -3.72 | Tick N/A |
| Bid 7.14 | Bid Size 100.00 | Ask 10.00 | Ask Size 500.00 |
| Open 9.16 | High 9.16 | Low 8.68 | Prev Close 9.14 |
| Last Trade | Volume 109,923 | 52 Wk Hi 14.63 | 52 Wk Low 6.27 |
| Market Cap 414.6 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 47,118,234.00 | EPS (TTM) -2.88 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 0 |
| Number of Buys | 0 | 0 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 0 |
| Last 10 Buys | Shares |
|---|---|
| Ran Frenkel | 1,000 |
| Ran Frenkel | 1,000 |
| Justin A. Renz | 1,000 |
| Barry E. Greene | 1,000 |
| Deepika R. Pakianathan | 1,000 |
| Deepika R. Pakianathan | 1,000 |
| Deepika R. Pakianathan | 1,000 |
| Deepika R. Pakianathan | 1,000 |
| Deepika R. Pakianathan | 1,000 |
| Deepika R. Pakianathan | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Michael G. Kauffman | 1,000 |
| Michael G. Kauffman | 1,000 |
| Sharon Shacham | 1,000 |
| Sharon Shacham | 1,000 |
| Mansoor Raza Mirza | 1,000 |
| Mansoor Raza Mirza | 1,000 |
| Mansoor Raza Mirza | 1,000 |
| Mansoor Raza Mirza | 1,000 |
| Michael G. Kauffman | 1,000 |
| Michael G. Kauffman | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 18 | 20 | 20 | 18 |
| Low Target Price Estimate | 8 | 8 | 9 | 8 |
| Mean Target Price Estimate | 13 | 14 | 14.29 | 13.29 |
| Standard Deviation | 3.9 | 4.43 | 4.03 | 3.64 |
| Date of Most Recent Estimate | 08/04/16 | 08/04/16 | 07/19/16 | 08/18/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 55 | 2016-08-04 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2016-08-04 |
| 4 | Statement of changes in beneficial ownership of securities | 2 | 2016-06-27 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-17 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 |
| Moderate Buy | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 |
| Moderate Sell | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.86 | 1.86 | 2 | 2 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
